|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date18 Jan 1966 |
100 Clinical Results associated with Shanghai Donghai Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shanghai Donghai Pharmaceutical Co., Ltd.
100 Deals associated with Shanghai Donghai Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shanghai Donghai Pharmaceutical Co., Ltd.